Items where authors include "Middleton, MR"

Article

Taylor, CA, Watson, RA, Tong, O et al. (22 more authors) (2022) IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine, 28 (12). pp. 2592-2600. ISSN 1078-8956

Cheng, VWT orcid.org/0000-0003-4159-8697, de Pennington, N, Zakaria, R et al. (13 more authors) (2022) VCAM-1-targeted magnetic resonance imaging improves detection of the tumor-brain interface. Clinical Cancer Research. ISSN 1078-0432

Thomas, A, Virdee, PS, Eatock, M et al. (10 more authors) (2020) Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. European Journal of Cancer, 124. pp. 131-141. ISSN 0959-8049

de Santiago, I, Yau, C, Heij, L et al. (5 more authors) (2019) Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes. International Journal of Cancer, 145 (4). pp. 1125-1137. ISSN 0020-7136

Cheng, VWT orcid.org/0000-0003-4159-8697, Soto, MS, Khrapitchev, AA et al. (5 more authors) (2019) VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors. Clinical Cancer Research, 25 (2). pp. 533-543. ISSN 1078-0432

Lipplaa, A, Fernandes, R, Marshall, A et al. (7 more authors) (2018) 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British Journal of Cancer, 119 (7). pp. 793-800. ISSN 0007-0920

Conference or Workshop Item

Milhem, MM, Vanderwalde, AM, Bowles, TL et al. (16 more authors) (2022) Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Illinois.